Prevalence and correlates of metabolic syndrome in patients with initial-treatment and drug-naïve bipolar disorder: A large sample cross-sectional study.

Patients with bipolar disorder (BD) are frequently prone to metabolic syndrome (MetS), and their co-morbidity adversely affects patient care outcomes. This study aimed to determine the prevalence of MetS and its clinical correlates among initial-treatment and drug-naïve (ITDN) BD patients.We recruit...

Full description

Saved in:
Bibliographic Details
Main Authors: Yilin Fang, Bingchuan Yan, Zhihua Liu, Lin Zhang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0328269
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849317304066637824
author Yilin Fang
Bingchuan Yan
Zhihua Liu
Lin Zhang
author_facet Yilin Fang
Bingchuan Yan
Zhihua Liu
Lin Zhang
author_sort Yilin Fang
collection DOAJ
description Patients with bipolar disorder (BD) are frequently prone to metabolic syndrome (MetS), and their co-morbidity adversely affects patient care outcomes. This study aimed to determine the prevalence of MetS and its clinical correlates among initial-treatment and drug-naïve (ITDN) BD patients.We recruited a cohort of 841 ITDN BD patients. Socio-demographic and clinical data were collected, and patients underwent routine serological testing, which included fasting blood glucose, lipid profiles, thyroid function, and prolactin levels. Psychometric evaluations were also conducted to measure manic, depressive, and psychotic symptoms, as well as illness severity. Additionally, we utilized a transformation approach for continuous variable analysis to compute a MetS score.We found a MetS prevalence of 17.84% among the study participants. Binary logistic regression identified age, body mass index (BMI), low-density lipoprotein cholesterol (LDL-C), free tetraiodothyronine (FT4), and psychotic symptoms as significant predictors of MetS development. Further, multiple linear regression analysis indicated that advanced age was a significant predictor of higher MetS scores.The findings highlight the prevalence of MetS in ITDN BD patients and suggest that certain demographic and clinical factors are influential in the development and severity of MetS. These insights may guide the development of targeted preventive and therapeutic strategies for MetS in this patient population.
format Article
id doaj-art-757d66736bff4c5ea24496cbeb85e5ee
institution Kabale University
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-757d66736bff4c5ea24496cbeb85e5ee2025-08-20T03:51:14ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01207e032826910.1371/journal.pone.0328269Prevalence and correlates of metabolic syndrome in patients with initial-treatment and drug-naïve bipolar disorder: A large sample cross-sectional study.Yilin FangBingchuan YanZhihua LiuLin ZhangPatients with bipolar disorder (BD) are frequently prone to metabolic syndrome (MetS), and their co-morbidity adversely affects patient care outcomes. This study aimed to determine the prevalence of MetS and its clinical correlates among initial-treatment and drug-naïve (ITDN) BD patients.We recruited a cohort of 841 ITDN BD patients. Socio-demographic and clinical data were collected, and patients underwent routine serological testing, which included fasting blood glucose, lipid profiles, thyroid function, and prolactin levels. Psychometric evaluations were also conducted to measure manic, depressive, and psychotic symptoms, as well as illness severity. Additionally, we utilized a transformation approach for continuous variable analysis to compute a MetS score.We found a MetS prevalence of 17.84% among the study participants. Binary logistic regression identified age, body mass index (BMI), low-density lipoprotein cholesterol (LDL-C), free tetraiodothyronine (FT4), and psychotic symptoms as significant predictors of MetS development. Further, multiple linear regression analysis indicated that advanced age was a significant predictor of higher MetS scores.The findings highlight the prevalence of MetS in ITDN BD patients and suggest that certain demographic and clinical factors are influential in the development and severity of MetS. These insights may guide the development of targeted preventive and therapeutic strategies for MetS in this patient population.https://doi.org/10.1371/journal.pone.0328269
spellingShingle Yilin Fang
Bingchuan Yan
Zhihua Liu
Lin Zhang
Prevalence and correlates of metabolic syndrome in patients with initial-treatment and drug-naïve bipolar disorder: A large sample cross-sectional study.
PLoS ONE
title Prevalence and correlates of metabolic syndrome in patients with initial-treatment and drug-naïve bipolar disorder: A large sample cross-sectional study.
title_full Prevalence and correlates of metabolic syndrome in patients with initial-treatment and drug-naïve bipolar disorder: A large sample cross-sectional study.
title_fullStr Prevalence and correlates of metabolic syndrome in patients with initial-treatment and drug-naïve bipolar disorder: A large sample cross-sectional study.
title_full_unstemmed Prevalence and correlates of metabolic syndrome in patients with initial-treatment and drug-naïve bipolar disorder: A large sample cross-sectional study.
title_short Prevalence and correlates of metabolic syndrome in patients with initial-treatment and drug-naïve bipolar disorder: A large sample cross-sectional study.
title_sort prevalence and correlates of metabolic syndrome in patients with initial treatment and drug naive bipolar disorder a large sample cross sectional study
url https://doi.org/10.1371/journal.pone.0328269
work_keys_str_mv AT yilinfang prevalenceandcorrelatesofmetabolicsyndromeinpatientswithinitialtreatmentanddrugnaivebipolardisorderalargesamplecrosssectionalstudy
AT bingchuanyan prevalenceandcorrelatesofmetabolicsyndromeinpatientswithinitialtreatmentanddrugnaivebipolardisorderalargesamplecrosssectionalstudy
AT zhihualiu prevalenceandcorrelatesofmetabolicsyndromeinpatientswithinitialtreatmentanddrugnaivebipolardisorderalargesamplecrosssectionalstudy
AT linzhang prevalenceandcorrelatesofmetabolicsyndromeinpatientswithinitialtreatmentanddrugnaivebipolardisorderalargesamplecrosssectionalstudy